Filing Analysis

πŸ“„ Other SEC Filing Filed Jun 16, 2026
βšͺ LOW

VirnetX Holding Corporation reported the results of its 2026 Annual Meeting of Stockholders held on June 11, 2026. Stockholders approved the election of Class I directors, the ratification of the accounting firm, executive compensation, and an increase in the share reserve for the 2013 Equity Incentive Plan.

πŸ“‹ Key Facts

  • Stockholders approved increasing the number of shares reserved for issuance under the Amended and Restated 2013 Equity Incentive Plan by 1,000,000 shares.
  • Farber Hass Hurley LLP was ratified as the independent registered accounting firm for the fiscal year ending December 31, 2026.
  • Kendall Larsen and Gary W. Feiner were elected as Class I directors to serve until the 2029 Annual Meeting.
  • Quorum was established with 2,639,678 shares represented, accounting for 63.06% of voting power as of April 16, 2026.
πŸ“ Material Agreement Filed Oct 17, 2025
βšͺ LOW

VirnetX Holding Corp announced it has been awarded a GSA Schedule Contract. This contract is intended to expand federal access to the company's secure communications and Zero-Trust cybersecurity solutions.

πŸ“‹ Key Facts

  • Company was awarded a GSA Schedule Contract on October 16, 2025.
  • The contract focuses on providing secure communications and Zero-Trust cybersecurity solutions to federal agencies.
  • Information was disclosed via Item 7.01 (Regulation FD Disclosure) as a press release.
⚠️ Delisting Notice Filed Sep 11, 2025
🟑 MEDIUM

VirnetX Holding Corp has notified the NYSE of its intention to voluntarily withdraw its common stock listing and transfer it to Nasdaq. The transition is expected to be completed between September 22 and September 23, 2025.

🚩 Red Flags

  • Voluntary delisting from a major exchange (NYSE) can sometimes signal liquidity concerns or a desire to reduce regulatory costs/compliance burdens, though it is often a strategic move for micro-caps.

πŸ“‹ Key Facts

  • The company is voluntarily withdrawing from the New York Stock Exchange (NYSE).
  • Listing on NYSE is expected to end at market close on or about September 22, 2025.
  • Trading on Nasdaq is expected to begin at market open on or about September 23, 2025.
  • The stock will continue to trade under the same ticker symbol: 'VHC'.
  • Nasdaq has already approved the listing of the Common Stock.
πŸ“„ Other SEC Filing Filed Jun 17, 2025
βšͺ LOW

VirnetX Holding Corporation held its 2025 Annual Meeting of Stockholders on June 12, 2025. The meeting resulted in the election of a Class III director and the ratification of Farber Hass Hurley LLP as the independent accounting firm.

πŸ“‹ Key Facts

  • The 2025 Annual Meeting was held on June 12, 2025.
  • Quorum was established by holders of 2,717,048 shares (64.10% of voting power).
  • Michael F. Angelo was elected to the Class III director position until the 2028 Annual Meeting.
  • Farber Hass Hurley LLP was ratified as the independent registered accounting firm for fiscal year ending Dec 31, 2025.
  • Stockholders approved executive compensation on an advisory basis.
⚠️ Delisting Notice Filed Sep 04, 2024
🟠 HIGH

VirnetX Holding Corp received a notice from the NYSE regarding non-compliance with minimum market capitalization standards. The company's 30-day average market cap was ~$23.9 million, falling below the $50 million requirement.

🚩 Red Flags

  • Delisting notice from NYSE
  • Market capitalization ($23.9M) is significantly below the $50M requirement
  • Stockholders' equity ($48.8M) is below the $50M threshold
  • Uncertainty regarding the ability to execute a plan to regain compliance

πŸ“‹ Key Facts

  • Received NYSE notice on August 28, 2024, for failure to meet Section 802.01B (Minimum Market Capitalization Standard).
  • The company's 30-day average market capitalization was approximately $23.9 million as of August 27, 2024.
  • Stockholders' equity was approximately $48.8 million as of June 30, 2024 (below the $50 million threshold).
  • The company has a 45-day window to submit a compliance plan and up to an 18-month cure period.
  • Trading on the NYSE continues during the cure period subject to NYSE approval of the compliance plan.
πŸ“„ Other SEC Filing Filed Jun 18, 2024
βšͺ LOW

VirnetX Holding Corp held its 2024 Annual Meeting of Stockholders on June 13, 2024. Shareholders approved an amendment to the 2013 Equity Incentive Plan and ratified several corporate governance matters.

πŸ“‹ Key Facts

  • Stockholders approved increasing the number of shares reserved for issuance under the Amended and Restated 2013 Equity Incentive Plan by 1,000,000 shares.
  • Thomas M. O’Brien and Heidy Chow were elected as Class II directors to serve until the 2027 Annual Meeting.
  • Farber Hass Hurley LLP was ratified as the independent registered accounting firm for the fiscal year ending December 31, 2024.
  • The meeting reached a quorum with 2,402,320 shares (65.27% of voting power) represented.
  • Advisory vote on executive compensation was approved.
Disclaimer: This analysis is generated by AI and is for informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Always review the original SEC filings and consult a financial advisor before making investment decisions.

Get real-time alerts for VHC

Subscribers receive AI-powered analysis within minutes of new SEC filings — not days later.

Start 14-Day Free Trial